Carboxyfullerene nanoparticles alleviate acute hepatic injury in severe hemorrhagic shock.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 27750099.
- Also identified by DOI 10.1016/j.biomaterials.2016.10.022.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Hemorrhagic shock/resuscitation involves overwhelming reactive oxygen species (ROS) that cause oxidative stress, inflammation, and subsequent tissue injury. We investigated the effects of the potent antioxidant carboxyfullerene (C<sub>3</sub>) on acute liver injury during hemorrhage shock/resuscitation. C<sub>3</sub> infusion reduced the alanine aminotransferase (ALT) activity, methemoglobin content, malondialdehyde content, myeloperoxidase activity and expression levels of tumor necrosis factor -α and interleukin-6; it increased superoxide dismutase activity in the liver. The histologic injury score and apoptotic index were also markedly decreased after C<sub>3</sub> treatment compared with the vehicle group. Additionally, C<sub>3</sub>-treated rats showed a significant decrease in nuclear factor-κB DNA binding capacity, which was preceded by reduced phosphorylation of the nuclear factor κB (NF-κB) p65 subunit in the liver. C<sub>3</sub> nanoparticles ameliorate oxidative stress, the inflammatory response, and subsequent acute liver injury after hemorrhagic shock/resuscitation. These protective effects appear to be mediated through the inhibition of the nuclear factor-κB pathway. C<sub>3</sub> treatment may be a promising strategy to improve tissue injury in hemorrhagic shock/resuscitation.
Medical subject headings
- Acute Lung Injury
- Carboxylic Acids
- Nanoparticles
- Reactive Oxygen Species
- Shock, Hemorrhagic